The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma

International Journal of Oncology

Volumn 35, Issue 1, 2009, Pages 175-179

  Yu, Jun ^a,b   Bulk, Etmar ^a   Ji, Ping ^a   Hascher, Antje ^a   Koschmieder, Steffen ^a   Berdel, Wolfgang E ^a   Müller Tidow, Carsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Elk 1; EPHB6; Extracellular signal regulated kinase; Mitogen activated protein kinase; Non small cell lung cancer; Receptor tyrosine kinase

Indexed keywords

EPHRIN RECEPTOR B6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; CELL LINE, TUMOR; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 67649440526     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000326     Document Type: Article

References (31)

1. Roux PP and Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344, 2004.
2. Baccarini M: Second nature: biological functions of the Raf-1 'kinase'. FEBS Lett 579: 3271-3277, 2005.
3. Meloche S and Pouysségur J: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239, 2007.
4. Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310, 2007.
5. Rubinfeld H and Seger R: The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31: 151-174, 2005.
6. Murphy LO and Blenis J: MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31: 268-275, 2006.
7. Dalby KN, Morrice N, Caudwell FB, Avruch J and Cohen P: Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 273: 1496-1505, 1998.
8. Marais R, Wynne J and Treisman R: The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-393, 1993.
9. Kortenjann M, Thomae O and Shaw PE: Inhibition of v-raf-dependent c-fos expression and transformation by a kinasedefective mutant of the mitogen-activated protein kinase Erk2. Mol Cell Biol 14: 4815-4824, 1994.
10. Owens DM and Keyse SM: Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203-3213, 2007.
11. Menzel P, Valencia F, Godement P, Dodelet VC and Pasquale EB: Ephrin-A6, a new ligand for EphA receptors in the developing visual system. Dev Biol 230: 74-88, 2001.
12. Eph Nomenclature Committee: Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90: 403-404, 1997.
13. Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM and Ikegaki N: Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas. Med Pediatr Oncol 36: 80-82, 2001.
14. Tang XX, Evans AE, Zhao H, et al: High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. Clin Cancer Res 5: 1491-1496, 1999.
15. Tang XX, Zhao H and Robinson ME: Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma. Med Pediatr Oncol 35: 656-658, 2000.
16. Tang XX, Zhao H, Robinson ME, et al: Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuro-blastoma. Proc Natl Acad Sci USA 97: 10936-10941, 2000.
17. Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M and Vogt T: Loss of EphB6 expression in metastatic melanoma. Int J Oncol 23: 1553-1559, 2003.
18. Hafner C, Schmitz G, Meyer S, et al: Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 50: 490-499, 2004.
19. Fox BP and Kandpal RP: Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Commun 318: 882-892, 2004.
20. Fox BP, Tabone CJ and Kandpal RP: Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. Biochem Biophys Res Commun 342: 1263-1272, 2006.
21. Muller-Tidow C, Diederichs S, Bulk E, et al: Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 65: 1778-1782, 2005.
22. Matsuoka H, Obama H, Kelly ML, Matsui T and Nakamoto M: Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. J Biol Chem 280: 29355-29363, 2005.
23. Tickenbrock L, Schwable J, Wiedehage M, et al: Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction. Blood 105: 3699-3706, 2005.
24. Freywald A, Sharfe N, Rashotte C, Grunberger T and Roifman CM: The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses. J Biol Chem 278: 10150-10156, 2003.
25. Hill CS and Treisman R: Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199-211, 1995.
26. Cavigelli M, Dolfi F, Claret FX and Karin M: Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14: 5957-5964, 1995.
27. Whitmarsh AJ, Shore P, Sharrocks AD and Davis RJ: Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407, 1995.
28. Sugimoto T, Stewart S, Han M and Guan KL: The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. EMBO J 17: 1717-1727, 1998.
29. Zhao C, Yu DH, Shen R and Feng GS: Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1. J Biol Chem 274: 19649-19654, 1999.
30. Smith ER, Capo-chichi CD, He J, et al: Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. J Biol Chem 276: 47303-47310, 2001.
31. Hongo S, Watanabe T, Takahashi K and Miyazaki A: Ndrg4 enhances NGF-induced ERK activation uncoupled with Elk-1 activation. J Cell Biochem 98: 185-193, 2006.